Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14326 - 14350 of 14745 in total
Experimental
CAD106 is an immunotherapeutic product in development for the treatment of Alzheimer's disease. It is designed to induce antibodies against the beta-amyloid-protein that inhibit the formation of plaques in the brain of Alzheimer's disease patients.
Investigational
R-95845 is an inhibitor of HIV-1 reverse transcriptase.
Experimental
BMS-488043 has been investigated as an anti-HIV agent.
Investigational
Investigational
Experimental
Illicit
Displaying drugs 14326 - 14350 of 14745 in total